Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis

NCT01209208 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphocytic Colitis

Interventions

DRUG: Budesonide
DRUG: Mesalamine
OTHER: Placebo

Sponsor

Dr. Falk Pharma GmbH